Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Range Cancer Therapeutics Index (CNCR)

Range Cancer Therapeutics Index (CNCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Range ETFs
  • Assets Under Management 10,524,400
  • Shares Outstanding, K 830
  • 60-Month Beta 0.90
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 1.853 on 12/29/21
  • Management Fee 0.79%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.62 +0.47%
on 12/13/24
14.59 -13.09%
on 11/14/24
-2.12 (-14.32%)
since 11/13/24
3-Month
12.62 +0.47%
on 12/13/24
16.27 -22.07%
on 09/16/24
-3.43 (-21.29%)
since 09/13/24
52-Week
12.37 +2.51%
on 12/14/23
17.96 -29.40%
on 03/01/24
+0.40 (+3.26%)
since 12/13/23

Most Recent Stories

More News
4 Solid ETFs Under $20 for Your Portfolio

Most investors want to invest in equities but may be unable to afford large stakes in valuable companies with higher-priced stocks. Lower-priced stocks could be attractive for them as they enable them...

DIV : 18.52 (+0.05%)
SFYX : 15.44 (+0.26%)
CNCR : 12.68 (-2.54%)
FXN : 16.64 (-0.58%)
5 ETFs That Led the Rebound on Monday

Wall Street recovered from its biggest weekly losses of the year on Monday, driven by bargain hunting and looming Fed rate cuts. The S&P 500, Nasdaq Composite Index and the Dow Jones Industrial Average...

CNCR : 12.68 (-2.54%)
MSOS : 3.77 (+4.72%)
DAPP : 18.45 (+0.16%)
WGMI : 27.36 (-1.79%)
AUMI : 36.71 (-3.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Range Cancer Therapeutics ETF seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Range Cancer Therapeutics Index.

See More

Top 10 Holdings

Name % Holdings

See More

Key Turning Points

3rd Resistance Point 13.19
2nd Resistance Point 13.07
1st Resistance Point 12.87
Last Price 12.68
1st Support Level 12.55
2nd Support Level 12.43
3rd Support Level 12.24

See More

52-Week High 17.96
Fibonacci 61.8% 15.82
Fibonacci 50% 15.16
Fibonacci 38.2% 14.51
Last Price 12.68
52-Week Low 12.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar